Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). (4th November 2015)
- Record Type:
- Journal Article
- Title:
- Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). (4th November 2015)
- Main Title:
- Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
- Authors:
- Powles, Thomas
Nickles, Dorothee
Van Allen, Eliezer
Chappey, Colombe
Zou, Wei
Kowanetz, Marcin
Kadel, Edward
Denker, Mitchell
Boyd, Zachary
Vogelzang, Nicholas
Kim, Joseph
Bellmunt, Joaquim
Loriot, Yohann
Drake, Charles G
O'Hear, Carol
Fasso, Marcella
Hegde, Priti
Mariathasan, Sanjeev - Abstract:
- Is Part Of:
- Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
- Journal:
- Journal for immunotherapy of cancer
- Issue:
- Volume 3(2015)Supplement 2
- Issue Display:
- Volume 3, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 3
- Issue:
- 2
- Issue Sort Value:
- 2015-0003-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-11-04
- Subjects:
- Immune Checkpoint -- Urothelial Bladder Cancer -- SP142 Antibody -- Stromal Signature -- Baseline Gene Expression
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105 - Journal URLs:
- http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/2051-1426-3-S2-P83 ↗
- Languages:
- English
- ISSNs:
- 2051-1426
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19195.xml